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Speculation
The reduced sialylation of desialylated preparations of purified az-macroglobulin from patients with cystic fibrosis as compared to that of asialo-a2-macroglobulin from age-and sex-matched normal controls indicates a possible alteration in the carbohydrate moiety of glycoproteins in cystic fibrosis. The metabolism of sialic acid appears, however, to be normal in this disease and could not account for the observed differences. Additional glycoproteins and glycosyltransferases should he examined to find out if a general defect in glycosylation is involved in cystic fibrosis.
enzymes studies, the results were inconsistent in the case of lysosomal hydrolases and highly dependent on the source of the enzyme and the type of the acceptor substrate in the case of glycosyltransferases.
Previous studies in our laboratory have documented that an altered as-macroglobulin ((YzM) is present in C F plasma. The asM from patients with C F demonstrated an abnormal interaction with various proteolytic enzymes (17) but was indistinguishable from normal azM by its antigenicity and ultraviolet absorbance spectra (18) . Two-dimensional electrophoretic analysis of purified apM preparations from C F and normal did not reveal any significant differences between the two s~e c i e s 18). However. the content of sialic acid was found to be reduced in' the C F a2M and its binding to the lectins concanavalin A and wheat germ agglutinin was lower than that of the normal (5).
The present study was undertaken to find out if a defect in the metabolism of glycoprotein-sialic acid is involved in cystic fibrosis. The enzymic activities leading to the de novo synthesis of sialic acid, the recycling of sialic acid from glycoconjugates by neuraminidases, the formation of the nucleotide-sugar, cytidine 5'-monophosphate (CMP)-sialic acid, and the sialylation process were studied in plasma and cultured skin fibroblasts from C F patients and normal controls.
MATERIALS AND METHODS
[6-''HI-N-~cet~l-D-mannosamine (ManNAc), 3 1.5 Ci/mmole. [4-'4C]-~-acetylneuraminic acid (NeuNAc), 49 mCi/mmole, and cytidine monophosphate-[9-"1-N-a~et~lneuraminic acid (CMPNeuNAc), 18.9 Ci/mmole were from New England Nuclear (Boston, MA). Adenosine 5'-triphosphate (ATP), cytidine 5'-triphosphate (CTP), nicotinamide adenine dinucleotide, nicotinamide adenine dinucleotide phosphate, phenylmethyl sulfonylfluoride, Cystic fibrosis (CF) is an autosomal recessive disorder, one of agarose-bound neuraminidase (Closrridiurn perftingens), soybean the most common genetic diseases among Caucasian populations trypsin inhibitor (type I-S), and phosphoenol pyruvic acid (PEP) (13) . The disease involves abnormality of all exocrine glands, were from Sigma Chemical (St. Louis, MO). ManNAc, NeuNAc, associated with highly viscous mucus secretions (9) . The major neuramine lactose (beef colostrum), and fetuin (fetal calf serum) manifestations are pancreatic exocrine deficiency, chronic pul-were from Calbiochem-Behring (LaJolla, CA). monary disease, and abnormally high sodium and chloride conSkin fibroblasts were obtained by punch biopsies from three centrations in sweat (13) . The disease is lethal, and death usually patients with C F and three normal controls. All were males 13 to occurs before or in early adulthood. Numerous biochemical ab-14 years of age. The cells at their third to fifth passage were normalities were reported in patients with C F but the basic cultured and harvested as previously described (4) . Fibroblast biochemical defect has not been as yet elucidated.
lysates were prepared in five volumes of distilled water by five Many studies have found altered glycoproteins in C F patients consecutive cycles of freezing and thawing. Whole homogenates ( I ) and these abnormal glycoproteins are thought to contribute to were used for enzyme assays, and boiled cell lysates served as the pulmonary and gastrointestinal pathology of the disease. blanks. Plasma was separated from fresh venous blood obtained Carbohydrate analyses of duodenal fluid (10) . sweat (14) . and from three patients with C F and three normal controls. All were rectal mucus (16) fractions from patients with C F have shown a n 12-to 14-year-old males. Blood was collected on 3.8 mg/ml increased ratio of L-fucose to sialic acid as compared to normal sodium citrate. and the protease inhibitors phenylmethyl sulfoncontrols. Altered carbohydrate composition was also reported in ylfluoride and soybean trypsin inhibitor were added at final the glycoprotein a-L-fucosidase. purified to homogeneity from concentrations of 0.1 and 0.16 mg/ml, respectively. Protein was liver of C F patients (2) . The amounts of D-mannose. N-acetyl-D-determined by the dye binding assay (6) using bovine y-globulin glucosamine, and sialic acid were reduced to 30 to 50% of their as a standard. Absorbance measurements were made on a Beckcontent in normal liver a-I.-fucosidase. Comparative studies on man D.B. spectrophotometer, and radioactivity of "H and I4C was the enzymes involved in the metabolism of the carbohydrate monitored by a Tricarb scintillation spectrometer. moiety of glycoproteins in C F patients and normal controls have Synthesis of sialic acid from N-acetyl-D-mannosamine (Fig. I . been reported for several glycosidases and glycosyltransferases (1, reactions 1 to 3) was assayed according to Warren and Glick (20) 13). Although altered levels of activity were found for some of the using fibroblast lysate as the source of enzymes. The reaction mixture contained 100 pg cell protein, 100 nmoles [6-%]ManNAc (6,800 dpm/nmole), 400 nmoles ATP, 2400 nmoles MgC12, 1600 nmoles PEP, 20 nmoles nicotinamide adenine dinucleotide and 20 nmoles nicotinamide adenine dinucleotide phosphate in a final volume of 0.2 ml of 0.1 M Tris-acetate buffer, pH 7.6. After incubation for 3 hr at 37°C. the sialic acid formed was either quantitated chemically by the thiobarbituric acid assay (3) or radioactively after separation from the radiolabeled precursor by descending paper chromatography (Whatman No. 3, 50 x 20 cm) in n-butanol/pyridine/water, 6/4/3 (by volume). The relative mobilities (Rf values) were 0.07 and 0.53 for NeuNAc and ManNAc, respectively. The corresponding areas were cut out from the chromatogram and placed in scintillation vials containing 10 ml Bray's solution (7) , and the radioactivity was measured.
The activity of fibroblast CTP:N-acylneuraminate cytidyltransferase (EC 2.7.7.43; Fig. I, reaction 4) was assayed according to Kean and Roseman (12) by incubating 100 pg cell lysate 4000 nmoles MgCI2, 1000 nmoles CTP, and 1000 nmoles [4-I4C] NeuNAc (10,800 dpm/nmole) for 2 hr at 37OC in final volume of 0.2 ml of 0.1 M Tris-HCI buffer, pH 8.2. The product, CMPNeuNAc. was isolated from the reaction mixture by descending paper chromatography (Whatman No. 3, 50 x 20 cm) in 0.1 M ammonium acetate buffer, pH 7.5, containing 70% ethanol. The RI values were 0.22 for CMP-NeuNAc and 0.61 for the free sialic acid.
CMP-NeuNAc:glycoprotein N-acetylneuraminyltransferase (EC 2.4.99.1; Fig. 1, reaction 5 ) activity was measured in plasma and fibroblast lysates using desialylated preparations of fetal calf serum fetuin and human plasma a2M as the glycoprotein acceptors. Purification of w2M from the three cystic fibrosis and three normal plasma samples was carried out as previously described (5) . Greater than 95% sialic acid (3) was removed by hydrolyzing the glycoprotein (5 mg/ml) for 1 hr at 80°C in 0.1 N H2S04. Neuraminidase treatment was used as an alternative method, and 55 to 65% of the initial sialic acid (3) was removed by this procedure. Agarose-bound neuraminidase was shaken for 24 hr at 37°C with 2.5 mg glycoprotein in 0.5 ml of 0. l M sodium acetate buffer, pH 5.0. Aliquots containing 0.1 unit enzyme each, were added initially and after 6 and 12 hr incubation. The insoluble neuraminidase was spun down, and sialic acid was discarded from the desialylated preparations by dialysis against 0. I M Tris-HCI buffer, pH 7.5. The sialylation mixture contained 50 p1 plasma or 100 pg fibroblast lysate protein, 0.2 mg fetuin or I mg aZM, and 150 nmoles CMP-[9-"HINeuNAc (41.8 x 10" dpm/nmole) in 0.2 ml of 0.1 M Tris-HCI buffer, pH 7.5. The reaction mixture was incubated for 2 hr at 37OC and terminated by adding 0.8 ml of 3% phosphotungstic acid in 0.5 N HCI. After 16 hr at 4OC. the glycoprotein precipitate was spun down (12,000 x g for 20 min) and washed twice in 1 ml of 2.4% phosphotungstic acid in 0.4 N HCI. The washed precipitate was dissolved in I ml of I N NaOH and the radioactivity was measured.
The activity of a-N-acetylneuraminidase (EC 3.2.1.18; Fig. 1,  reaction 6 ) toward neuramine lactose, a2M, and fetuin was assayed using fibroblast lysate prepared by I -to 2-sec sonication of freshly harvested cells in five volumes of distilled water. The reaction mixture contained 100 pg fibroblast protein and 2000 nmoles neuramine lactose, 1 nmole anM or 50 nmoles fetuin in 0.2 ml of 0.1 M sodium acetate buffer, pH 4.3. The sialic acid released was determined by the thiobarbituric acid assay (3).
RESULTS
The rate of synthesis of sialic acid from N-acetyl-~mannosa-mine (Fig. 1, reactions 1 to 3 ) in cultured skin fibroblast of three patients with C F and three age-and sex-matched normal controls is shown in Table I . The assays were performed in duplicate that agreed within 5%. The production of sialic acid by fibroblasts of the C F patients was within the range obtained for the normal controls. The direct chemical determination of the sialic acid formed agreed with the determination of its radioactivity after chromatographic separation from the radiolabeled precursor. Omission of ATP or PEP from the reaction mixture resulted in poor synthesis of sialic acid (less than 5%) by both the C F and the normal fibroblast lysates. All assays used boiled cell lvsates as enzyme blanks.
The activity of CTP:NeuNAc cytidylyltransferase ( Fig. 1 . reaction 4) in fibroblast lysates from three C F patients (0.417 f 0.1 17 nmoles/hr/mg protein) did not differ significantly from that of three normal controls (0.470 f 0.1 10 nmoles/hr/mg protein). Addition of asialofetuin to the reaction mixture (Fig. I , reaction 5) resulted in a slight decrease in CMP-NeuNAc formed and an increased incorporation of sialic acid into the high-molecularweight fraction which does not migrate in the chomatography system. Figure 2 illustrates similar chromatographic patterns of radioactivity obtained with C F and normal fibroblast lysates after incubation with CTP, [ 4 -' 4~] ~e u N A c , and asialofetuin. Incubation of either type of cell lysate with radiolabeled sialic acid and asialofetuin but no CTP did not show any significant incorporation into the glycoprotein fraction. 
BEN-YOSEF
The activation of the free sialic acid by formation of CMP-sialic acid is a prerequisite for the sialylation step in which sialic acid is transferred from the nucleotide sugar donor into a glycoprotein acceptor. The activity of CTP:sialic acid cytidylyltransferase in CF fibroblasts did not differ significantly from that of normal cells, and addition of asialofetuin into the reaction mixture resulted in similar pattern of incorporation for both cell types. In contrast to asialofetuin, the sialylation of desialylated preparations of purified a2M from CF plasma was poor and found to be 48 to 65% of that determined for desialylated preparations of normal anM. However, the reduced sialylation of CF azM could not be attributed to a defective sialyltransferase because similar results were observed using plasma or fibroblast from either CF patients or normal controls, as the enzyme source. Both the CF and the normal enzyme possessed relatively high activity toward normal aSM, whereas the CF CYZM species was a poor glycoprotein substrate. The decreased content of sialic acid, previously found (5) for CF a2M, may account for the reduced sialylation of this glycoprotein specks. An opposite pattern has been reported (1 1) for the fucosylation reaction in CF, namely, using fucosyltransferase from either CF or normal plasma, the incorporation of Lfucose into a glycoprotein acceptor from CF saliva was significantly higher than the incorporation into the glycoprotein acceptor from control. The decreased sialylation and increased fucosylation of CF glycoproteins are in agreement with the previously reported (1) decreased ratio of sialic acid to L-fucose in glycoprotein fractions from CF patients.
The enzymes involved in the metabolism of sialic acid in CF patients appear to be normal and could not account for the observed differences. The altered carbohydrate composition and the altered glycosylation reactions of CF glycoproteins are probably the result of a defect prior to the sialylation of the oligosaccharide portion. The metabolism of additional glycoprotein sugars should be examined to find out if a general defect in the glycosylation process might be involved in CF.
